Department of Health and Human Services May 28, 2008 – Federal Register Recent Federal Regulation Documents

Potential for a Registry of Breast Cancer Treatment Using Thermal Ablation Devices; Request for Comments
Document Number: E8-11899
Type: Notice
Date: 2008-05-28
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is requesting comments on whether a registry could facilitate standardization of feasibility trials studying local treatment of small breast cancers with different thermal ablation devices and therapies (i.e. cryoablation, focused ultrasound, interstitial laser, microwave, radiofrequency ablation). FDA is specifically interested in understanding how breast cancer ablation feasibility trials can be constructed so that there exists standardized evaluation of tissue biopsy pathology, selection of tumors amenable to ablation, image guidance for ablation, post-ablation imaging and assessment, and tissue pathology of ablated specimens. The agency seeks to facilitate its understanding of local treatment for breast cancer using thermal ablation devices.
National Center for Injury Prevention and Control/Initial Review Group, (NCIPC/IRG)
Document Number: E8-11720
Type: Notice
Date: 2008-05-28
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Medicare Program; Medicare Part D Claims Data
Document Number: 08-1298
Type: Rule
Date: 2008-05-28
Agency: Department of Health and Human Services, Part II, Centers for Medicare & Medicaid Services
This final rule allows the Secretary to collect claims data that are presently being collected for Part D payment purposes for other research, analysis, reporting, and public health functions. The Secretary needs to use these data because other publicly available data are not, in and of themselves, sufficient for the studies and operations that the Secretary needs to undertake as part of the Department of Health and Human Service's obligation to oversee the Medicare program, protect the public's health, and respond to Congressional mandates. These data will also be used to better identify, evaluate and measure the effects of the Medicare Modernization Act of 2003, (MMA).